Role of TGFbeta signaling in HNSCC progression
Role of TGFbeta signaling in HNSCC progression
批准号:
8032443
负责人:
Xiao-Jing Wang
金额:
$41.83万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-01 至 2015-01-31
关键词:
4-Hydroxy-TamoxifenAbbreviationsAlcoholsAnthracenesBenignBindingBiological MarkersBiologyCancer PrognosisCellsChronicCollagenCountryDataDefectDevelopmentDown-RegulationElementsEnvironmental CarcinogensEpithelialEpithelial CellsEpitheliumEventExperimental ModelsFamily memberFanconi&aposs AnemiaFibroblastsFundingGene TargetingGenesGenetically Engineered MouseGenomic InstabilityGoalsHRAS geneHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and neck structureHumanImmunohistochemistryInflammationLeadLoss of HeterozygosityMalignant ConversionMalignant NeoplasmsMatrix MetalloproteinasesMediatingMesenchymalMicroarray AnalysisMolecularMolecular TargetMouth NeoplasmsMusMutationOncogenicPathway AnalysisPathway interactionsPatientsPlayPoly(ADP-ribose) PolymerasesProductionRoleSignal PathwaySignal TransductionSquamous cell carcinomaSystemTestingTherapeuticTissuesTobaccoTransforming Growth Factor betaTransforming Growth FactorsUp-RegulationVascular Endothelial Growth Factorsangiogenesisbasecancer therapycancer typecarcinogenesischemical carcinogenchromatin immunoprecipitationcomparative genomic hybridizationcytokinedimethylbenzanthracenegenome wide association studygenome-wideimprovedlaser capture microdissectionmacrophage stimulating proteinmembermouse modelnovel therapeutic interventionoral fibroblastoral tissueoutcome forecastoverexpressionparacrinepromoterpublic health relevancereceptortumor
中文摘要
描述(由申请人提供):长期目标是鉴定可用于HNSCC预后和治疗的分子靶点。 头颈部鳞状细胞癌(HNSCC)是西方国家第六常见的癌症类型。 HNSCC的主要病因是环境致癌物,例如,烟草和酒精,导致遗传改变和头颈部(H&N)组织的慢性炎症。 在本申请中,我们将使用可诱导的H& N特异性基因靶向系统将人HNSCC中常见的TGF β信号通路中的几种遗传改变引入小鼠H&N组织,并评估这些改变促进HNSCC发展的机制。 目的1将研究Smad 4缺失介导的HNSCC发展的分子机制。 我们将评估任何Fanc/Brca成员是否是Smad 4的直接转录靶点,以及Smad 4-/-HNSCC中VEGF过表达是否是Smad 3激活的结果并有助于Smad 4缺失介导的HNSCC致癌作用。 将进行全基因组分析以鉴定由Smad 4缺失引起的其他改变,其有助于对H&N上皮和基质的致癌作用。 目的2将评估Smad 2缺失在HNSCC促进中的作用。 我们将确定在Kras突变存在的情况下,Smad 2缺失是否促进HNSCC的形成和进展。 我们将分析在Smad 2-/-组织中发现的HGF信号传导增加是否有助于Smad 2丢失相关的致癌作用,并研究Smad 2-/-细胞中HGF上调的机制。 还将进行全基因组筛选以鉴定H&N组织中Smad 2缺失引起的分子改变。 目的3将评估间质TGF β RII损失在HNSCC发展中的作用。 我们将诱导TGF?口腔成纤维细胞中的RII缺失,以确定在H&N上皮中存在化学致癌物诱导的H-ras突变或TGF β RII缺失的情况下,这是否会诱导或促进HNSCC形成。 将分析口腔成纤维细胞TGF β RII缺失引起的病理学和分子学改变。 这些研究不仅将提高我们对HNSCC生物学的理解,而且还将直接测试具有特定TGF信号缺陷的HSNCC的治疗方法。
公共卫生相关性:该应用程序将使用最先进的实验模型和方法来确定导致头颈癌形成和进展的分子机制。 拟议的研究将导致识别可用于改善癌症预后和治疗的生物标志物。
英文摘要
DESCRIPTION (provided by applicant): The long term goal is to identify molecular targets that can be used for prognosis and therapy of HNSCC. Head & neck squamous cell carcinomas (HNSCC) represent the 6th most common cancer type in western countries. The major HNSCC etiological factors are environmental carcinogens, e.g., tobacco and alcohol, which cause genetic alterations and chronic inflammation in head & neck (H&N) tissues. In this application, we will use an inducible H&N-specific gene targeting system to introduce several genetic alterations in the TGF¿ signaling pathway, which are common in human HNSCC, into mouse H&N tissues, and assess the mechanisms by which these alterations promote HNSCC development. Aim 1 will examine molecular mechanisms of Smad4 loss-mediated HNSCC development. We will assess if any Fanc/Brca members are direct Smad4 transcriptional targets, and if VEGF overexpression in Smad4-/- HNSCCs is the result of Smad3 activation and contributes to Smad4 loss-mediated HNSCC carcinogenesis. Genome-wide analyses will be performed to identify additional alterations caused by Smad4 loss, which contribute to oncogenic effects on H&N epithelia and stroma. Aim 2 will assess the role of Smad2 loss in HNSCC promotion. We will determine if Smad2 loss promotes HNSCC formation and progression in the presence of a Kras mutation. We will analyze if increased HGF signaling found in Smad2-/- tissues contributes to Smad2 loss-associated oncogenic effects and study the mechanisms of HGF upregulation in Smad2-/- cells. Genome-wide screens will also be performed to identify molecular alterations caused by Smad2 loss in H&N tissues. Aim 3 will assess the role of stromal TGF¿RII loss in HNSCC development. We will induce TGF¿RII deletion in oral fibroblasts to ascertain if this will induce or promote HNSCC formation in the presence of either a chemical carcinogen-induced H-ras mutation or TGF¿RII deletion in H&N epithelia. Pathological and molecular alterations caused by oral fibroblast TGF¿RII deletion will be analyzed. These studies will not only improve our understanding of HNSCC biology, but will also directly test therapeutic approaches in HSNCC with specific TGF¿ signaling defects.
PUBLIC HEALTH RELEVANCE: The application will use state-of-the-art experimental models and approaches to identify molecular mechanisms that cause head & neck cancer formation and progression. The proposed studies will lead to the identification of biomarkers that can be used to improve cancer prognosis and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application
-
批准号:10796340
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Xiao-Jing Wang
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10594019
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Xiao-Jing Wang
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10481521
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Xiao-Jing Wang
-
依托单位:
Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.
-
批准号:10477461
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2021
-
负责人:Xiao-Jing Wang
-
依托单位:
Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.
-
批准号:10704598
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2021
-
负责人:Xiao-Jing Wang
-
依托单位:
Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.
-
批准号:10268846
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2021
-
负责人:Xiao-Jing Wang
-
依托单位:
Proprietary drug to treat radiodermatitis
-
批准号:10269035
-
项目类别:
-
资助金额:$52.29万
-
财政年份:2020
-
负责人:Xiao-Jing Wang
-
依托单位:
Mechanisms of Breaking Indolence in Squamous Cell Carcinoma
-
批准号:9137250
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Xiao-Jing Wang
-
依托单位:
Mechanisms and Therapeutic Targets of SCC Metastasis
-
批准号:10731726
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Xiao-Jing Wang
-
依托单位:
Mechanisms and Therapeutic Targets of SCC Metastasis
-
批准号:10356069
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Xiao-Jing Wang
-
依托单位:
Testing Smad7-based biologics for treating chronic wounds
-
批准号:8779367
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2014
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:8474422
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:9404554
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:9233493
-
项目类别:
-
资助金额:$3.59万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:9000472
-
项目类别:
-
资助金额:$3.52万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:10207520
-
项目类别:
-
资助金额:$53.07万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:8643778
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:9044548
-
项目类别:
-
资助金额:$43.94万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Training in Translational Research of Lung, Head and Neck Cancer
-
批准号:8907402
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2013
-
负责人:Xiao-Jing Wang
-
依托单位:
Effects of altering TGF beta signaling on wound healing
-
批准号:8185645
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2011
-
负责人:Xiao-Jing Wang
-
依托单位:
海外基金